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Two-Year Outcomes After Conventional or Endovascular Repair of
Abdominal Aortic Aneurysms
Blakensteijn J.D., de Jong S.E.C.A., Prinssen M, et al
New England Journal of Medicine 2005; 352:2398-2405
Conclusion: Early survival advantage of endovascular repair over con-
ventional repair for abdominal aortic aneurysm (AAA) is not maintained
after the first postoperative year.
Summary: This is the two-year result of the Dutch randomized endo-
vascular aneurysm management trial (DREAM). The trial included 351
patients with AAA at least 5cm in diameter and considered suitable for either
endovascular or open aneurysm repair. Patients were randomized to either
open or endovascular repair and survival after randomization calculated
using Kaplan-Meier analysis. Analysis was on an intention to treat basis.
Two years following randomization cumulative survival rates were
89.6% for open repair and 89.7% for endovascular repair (difference,0.1%;
95% CI, 6.8 - 6.7%). With regard to aneurysm related death, cumulative
rates were 5.7% for open repair and 2.1% for endovascular repair (difference,
3.7%; 95% CI, 0.5 – 7.9%). This difference was entirely related to periop-
erative events. There was no significant difference in subsequent aneurysm-
related mortality. At two years, survival free of moderate or severe compli-
cations was similar in the open and endovascular groups (65.9% for open
repair and 65.6% for endovascular repair; difference, 0.3%; 95% CI,10.0 –
10.6%). During the first nine months after randomization, rate of interven-
tion after endovascular repair was about 3 times the rate after open repair
(hazard ratio 2.9; 95% CI, 1.1 – 6.2; p  0.03). After nine months
reintervention rates were roughly parallel between the two groups (hazard
ratio 1.1; 95% CI, 0.1 – 9.3; P  0.95).
Comment: The results of this analysis are a bit surprising. One would
have thought, based on the randomization process, that the initial survival
advantage of the endovascular treated patients would have been maintained.
In addition, one might have suspected that re-interventions for problems
with the endovascular repair would have continued to mount over time.
Instead, survival advantage was not maintained and re-interventions for
endovascular treated patients after nine months did not differ than those for
patients treated open. Clearly, efforts must be intensified using medical
management to maintain the survival advantage initially conferred by endo-
vascular aneurysm repair. It is unclear whether the stabilization of re-
interventions in the endovascular group after nine months is related to
stabilization of the endograft or perhaps changing management practice of
endoleaks.
Screening for Abdominal Aortic Aneurysms: Single-Centre Random-
ized Control Trial
Lindholt, JS, Juul S, Fasting H
British Medical Journal 2005; 330:750-752
Conclusion: Screening for abdominal aortic aneurysm (AAA) in men
aged 65 or more reduces aneurysm related mortality.
Summary: The authors sought to determine whether screening of
men 65 years of age or more for AAA reduces mortality. This was a single
center randomized control trial conducted at five hospitals in Viborg
County, Denmark. Participants included all 12,639 men born during
1921-33 and who are living in Viborg County. In 1994, men born
between 1921 and 1929 (64-73 years) were also included. Included also
were men who became 65 during the period 1995-1998. Participants
were randomized to an intervention or control group. Intervention
consisted of screening for AAA by ultrasonography. Those individuals
discovered to have an AAA 5cm were evaluated for surgery and those
with smaller aneurysms were offered annual follow-up ultrasound exam-
inations. The endpoints included specific mortality due to AAA, overall
mortality, and emergency operations for AAA.
6,333 men were offered screening, and 4,860 were actually screened
(screening rate 76.5%). Four percent of the individuals screened (n  191)
had an AAA. Mean follow-up was 52 months. During follow-up the
screened group had 75% fewer emergency operations than the control
group (95% confidence interval, 34-31%). There were 27 deaths due to AAA
in the control group and 9 in the screened group. Aneurysm related
mortality was reduced by 67% (95% CI 29-84%). The number of individuals
required to screen to save one life was 352. All cause mortality was insignif-
icantly decreased in the screened group (hazard ratio 0.92, 0.84-1.00).
Mortality from other causes was not significantly decreased (hazard ratio
0.92, 0.85-1.02).
Comment: This is another one of the four major randomized trials
evaluating the efficacy of screening for AAA. This trial, along with two of the
other trials, only evaluated men. There is one of the pivotal trials utilized by
theU.S. Preventative Task Force in generating recommendations for screen-
ing males for AAA who are, or had been, smokers and are aged 65-74 years.
Use of Quantitative Magnetic Resonance Angiography To Stratify
Stroke Risk in Symptomatic Vertebrobasilar Disease
Amin-Hanjani S, Du X, Zhao M, et al
Stroke 2005; 36:1140-1145
Conclusion: Quantitative magnetic resonance angiography (QMRA)
can stratify risk for stroke in patients with symptomatic vertebrobasilar
disease (VBD).
Summary: Phase-contrast quantitative magnetic resonance angiogra-
phy (QMRA) is a magnetic resonance technique for noninvasively measur-
ing blood flow in intracranial vessels (Mag Reson Imaging 2000; 18:697-
706). The authors utilized a standard protocol that included QMRA to
evaluate patients with symptomatic VBD. QMRA was used to stratify
patients based on presence of absence of flow compromise distal to the site
of VBD. Flow was considered compromised in specific vessels if it was
reduced greater than 20% of the lower limit of normal baseline value for that
vessel. Flow compromise was evaluated in the basilar and posterior cerebral
arteries. The basilar artery was designated as having reduced flow if flow
measurements were less than 12cc per minute and posterior cerebral arteries
were designated as having reduced flow if flow measurements were less than
40cc per minute. Patients with low distal flows were then either offered
surgical or endovascular intervention with other patients receiving standard
medical therapy. The paper reports the results of this protocol for patients
managed from 1998 to 2003. There were 50 patients subjected to the
protocol and 47 available for follow up over a mean interval of 28 months.
Kaplan-Meier curves were used to calculate stroke and stroke free survival at
two years and a combination of stroke free survival and freedom from
transient ischemic attacks at 2 years.
Patients with normal distal flow (n  31) had event free survivals of
100% and 96% respectively. At 2 years patients with low distal flows had a
71% event free survival with respect to stroke and a 53% event free survival
with respect to the combined endpoint of stroke and transient ischemic
attack. Patients with low distal flows had a higher risk of recurrent ischemia
(p  0.003). Twelve patients with low flow underwent treatment and had
82% event free survival. Using Cox proportional analysis flow status effected
event free survival independent of covariants.
Comment: Patients with symptomatic vertebrobasilar disease can be
offered intervention for large vessels stenoses that are felt to be hemodynam-
ically significant. However, collateralization in the posterior circulation can
be extensive and the presence of hemodynamically significant lesions in the
proximal vessels does not necessarily result in diminished posterior circula-
tion blood flow. The use of quantitative magnetic resonance angiography
may provide a method of selection for intervention for those patients with
vertebrobasilar disease most likely to benefit from an open or endovascular
surgical procedure. This paper may represent a major step forward for
selection of patients for vertebral artery reconstruction.
Gender Differences and Outcome of Conservatively Treated Patients
with Asymptomatic High-grade Carotid Stenosis
Dick P, Sherif C, Sabeti S, et al
Stroke 2005; 36:1178-1183
Conclusion:Males with high-grade carotid stenosis have a higher risk
of poor outcome than females with high-grade carotid artery stenosis.
Summary: This study examined gender differences in all forms of
vascular outcome and mortality in patients with high-grade carotid stenosis
and no neurologic symptoms. There were 525 patients enrolled, 325 males,
median age 72 years, and 200 females median age 75 years. All patients were
enrolled in a single center registry and were treated medically for asymptom-
atic greater than 70% internal carotid artery stenoses. Median follow up was
38 months (interquartile range 18-65 months). Patients were followed for
major adverse carodiovascular, cerebral, and peripheral vascular events. A
combined endpoint included stroke, myocardial infarction, vascular mortal-
ity, partial limb amputation and death (MACE). Cumulative MACE-free
survival rates in females and males at 1, 3, and 5 years, were 85%, 73%, and
67%, versus 83%, 65%, and 48% (p  0.004). Adjusted hazard ratios for
MACE, vascular mortality and all causemortality at 1, 3 and 5 years for males
compared with females were 1.96 (p 0.016), 2.48 (p 0.001), and 1.70
(p 0.007). This was irrespective of age, vascular risk factors, comorbidities
and individual risk status determined by the American Society of Anesthesi-
ologists.
Comment: The authors found male patients with asymptomatic high-
grade carotid stenosis do more poorly than female counterparts. The find-
ings are irrespective of vascular risk factors, comorbidities and age. Gender
related differences in outcomes of patients with asymptomatic high-grade
carotid stenosis may have some implication for monitoring as well as
strategies for intervention and prophylactic repair of asymptomatic high-
grade carotid stenosis.
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